When I first saw the sample size - 1,087,803 participants - I figured this was worth reading closely. Most alcohol-and-liver studies work with thousands. This one enrolled over a million South Korean men and followed them for 11 years. A dataset that size tends to settle arguments.

The argument it's settling: whether alcohol guidelines developed on Western populations apply to East Asian men with fatty liver. The short answer is no, and the reason traces back to a single gene.

What they did

Researchers pulled men aged 40 and older with MASLD from South Korea's 2011-2012 national health examinations. MASLD - metabolic dysfunction-associated steatotic liver disease - is the current umbrella term for fatty liver tied to metabolic factors like obesity and insulin resistance, not to drinking itself. That matters: the cohort started with men who already had some liver vulnerability before alcohol entered the picture.

Alcohol intake was sorted into five categories: none, under 70 g/week, 70-140 g/week, 140-210 g/week, and 210 g or more per week. A standard US drink contains roughly 14 g of pure alcohol, so 70 g/week works out to about 5 drinks spread over seven days.

The primary outcome was liver-related events (LREs): newly diagnosed hepatocellular carcinoma, cirrhosis with or without decompensation, and liver-related death. Median follow-up: 11 years.

What they found

26,742 participants (2.5%) developed an LRE during follow-up.

The dose-response was J-shaped. The lowest drinking tier - under 70 g/week - showed no significant elevated risk compared to not drinking at all. Above that floor, risk climbed:

  • 70-140 g/week. No significant increase in the full cohort. In vulnerable subgroups - men with diabetes, BMI under 25, or abnormal alanine aminotransferase levels - risk rose at this tier.
  • 140-210 g/week. Adjusted hazard ratio 1.10 (95% CI: 1.05-1.14).
  • 210+ g/week. Adjusted hazard ratio 1.30 (95% CI: 1.25-1.34).

Spline analysis confirmed the nonlinear shape: risk doesn't climb evenly with each additional drink but accelerates past the threshold.

What it means

The mechanism runs through ALDH2 (aldehyde dehydrogenase 2, a gene that helps the body break down alcohol). Many East Asians carry a variant that reduces ALDH2 activity. When ALDH2 function is impaired, acetaldehyde - a toxic intermediate in alcohol metabolism - accumulates faster at lower doses. Standard guidelines were calibrated on populations where this variant is rare.

The J-shape matters, and not in the obvious way. Even in this vulnerable population, the lowest drinking tier showed no significant elevated risk. The finding is about where the threshold sits, NOT about whether one exists.

The part worth taking seriously is the subgroup data. Men with diabetes or elevated liver enzymes saw their risk curve shift at 70-140 g/week - earlier than the general cohort, and well below where most clinical guidelines would flag concern.

The study has limits. It's male-only. ALDH2 variant frequency varies within East Asian populations, and the researchers inferred genetic risk from ethnicity rather than direct genotyping. These numbers apply specifically to men with MASLD, not to all East Asian drinkers. But a sample of 1 million followed for 11 years is large enough to trust the general shape of what they found.

The practical question is whether the reference ranges your doctor uses were calibrated for your biology. For East Asian men with a fatty liver diagnosis, this study suggests they probably weren't.

Source: Clinical Gastroenterology and Hepatology, DOI